However, in NICTH, IGF-2 is grossly overexpressed by tumor cells, especially of mesenchymal and epithelial origin, exerting an insulin-like effect on the body, promoting hypoglycemia by binding both IGF receptors and insulin receptors. This evidence concerns the gene IGF2 and neoplasm.